News

A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.
The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.
President Donald Trump promised on the campaign trail that he'd go after Mexico's drug cartels ... Defense Secretary Pete Hegseth whether the administration would use the military against cartels ...
Kennedy Jr. and U.S. Food and Drug Administration Commissioner Marty Makary will share more about the administration’s plans on Tuesday, the advisory said. In January, when former President Joe ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid. By Margot Sanger ...
Late last week, the Trump administration’s CMS announced that it is not finalizing a provision proposed by the Biden administration that would expand coverage of anti-obesity drugs under ...
Kennedy Jr. and U.S. Food and Drug Administration Commissioner Marty Makary will share more about the administration’s plans on Tuesday, the advisory said. In January, when former President Joe Biden ...
Health and Human Services Secretary Robert F. Kennedy will cut 3,500 jobs from the Food and Drug Administration, according to the fact sheet. "This reduction will not affect drug, medical device ...
Acting on the complaint of the Food and Drugs Administration (FDA) authorities, the Begampura police registered an offence against four people as per enabling provisions of the Drugs and Cosmetics ...
You can reach Helen on Signal at hbranswell.01. Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on ...